Northwestern Mutual Wealth Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-25
| Closed | -$644 | – | 4190 |
|
|
2025
Q3 | $644 | Buy |
+25
| New | +$614 | ﹤0.01% | 3611 |
|
|
2024
Q2 | – | Sell |
-1
| Closed | -$29 | – | 3733 |
|
|
2024
Q1 | $29 | Hold |
1
| – | – | ﹤0.01% | 3498 |
|
|
2023
Q4 | $34 | Buy |
+1
| New | +$29 | ﹤0.01% | 3415 |
|
|
2023
Q2 | – | Sell |
-5
| Closed | -$204 | – | 3535 |
|
|
2023
Q1 | $204 | Buy |
+5
| New | +$199 | ﹤0.01% | 3184 |
|
|
2022
Q3 | – | Sell |
-16
| Closed | -$1K | – | 3317 |
|
|
2022
Q2 | $1K | Buy |
+16
| New | +$1.05K | ﹤0.01% | 3062 |
|
|
2021
Q3 | – | Sell |
-36
| Closed | -$2K | – | 3161 |
|
|
2021
Q2 | $2K | Buy |
+36
| New | +$2.28K | ﹤0.01% | 2824 |
|
|
2019
Q4 | – | Sell |
-29
| Closed | -$1K | – | 2562 |
|
|
2019
Q3 | $1K | Buy |
+29
| New | +$1.16K | ﹤0.01% | 2381 |
|
|
2018
Q3 | – | Sell |
-11
| Closed | – | – | 2592 |
|
|
2018
Q2 | $0 | Buy |
+11
| New | +$380 | ﹤0.01% | 2462 |
|
|
2017
Q1 | – | Sell |
-10
| Closed | – | – | 2294 |
|
|
2016
Q4 | $0 | Buy |
+10
| New | +$334 | ﹤0.01% | 2374 |
|
|
2016
Q3 | – | Sell |
-72
| Closed | -$2K | – | 1130 |
|
|
2016
Q2 | $2K | Buy |
+72
| New | +$3.54K | ﹤0.01% | 1850 |
|
|
2016
Q1 | – | Sell |
-300
| Closed | -$23K | – | 2244 |
|
|
2015
Q4 | $23K | Buy |
+300
| New | +$17K | ﹤0.01% | 970 |
|
|
2015
Q1 | – | Sell |
-29
| Closed | -$3K | – | 1739 |
|
|
2014
Q4 | $3K | Buy |
+29
| New | +$2.74K | ﹤0.01% | 1427 |
|
Other funds holding PCRX
DPCM
